5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide

C110H167N25O10 — CID 157458762

IUPAC5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide
SMILESCC(C)N1C[C@@H](C)[C@H](NC(=O)C2=CC=C(C3CC3)C(=O)C2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cnc(C3CC3)cn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2coc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2cc(C3CC3)[nH]n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2ncc(C3CC3)cn2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2nccc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2nnc(C3CC3)o2)C1
InChIInChI=1S/C18H26N2O2.3C16H24N4O.C15H24N4O.C15H23N3O2.C14H22N4O2/c1-11(2)20-9-12(3)16(10-20)19-18(22)14-6-7-15(13-4-5-13)17(21)8-14;1-10(2)20-8-11(3)15(9-20)19-16(21)14-7-17-13(6-18-14)12-4-5-12;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-6-13(7-18-15)12-4-5-12;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-7-6-13(18-15)12-4-5-12;1-9(2)19-7-10(3)14(8-19)16-15(20)13-6-12(17-18-13)11-4-5-11;1-9(2)18-6-10(3)12(7-18)16-14(19)13-8-20-15(17-13)11-4-5-11;1-8(2)18-6-9(3)11(7-18)15-12(19)14-17-16-13(20-14)10-4-5-10/h6-7,11-13,16H,4-5,8-10H2,1-3H3,(H,19,22);6-7,10-12,15H,4-5,8-9H2,1-3H3,(H,19,21);2*6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-11,14H,4-5,7-8H2,1-3H3,(H,16,20)(H,17,18);8-12H,4-7H2,1-3H3,(H,16,19);8-11H,4-7H2,1-3H3,(H,15,19)/t12-,16-;11-,15-;2*11-,14+;10-,14+;10-,12-;9-,11+/m1100010/s1
InChIKeyBTRDQKPCXUKLKE-TXQLYQITSA-N
MW1999.71 g/mol
LogP12.67
Rot. Bonds28

About 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide

5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide (PubChem CID 157458762) has the molecular formula C110H167N25O10 and a molecular weight of 1999.71 g/mol. Its IUPAC name is 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide.

Molecular Properties

Compound Name5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide
PubChem CID157458762
Molecular FormulaC110H167N25O10
Molecular Weight1999.71 g/mol
Exact Mass1998.33
IUPAC Name5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide
SMILESCC(C)N1C[C@@H](C)[C@H](NC(=O)C2=CC=C(C3CC3)C(=O)C2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cnc(C3CC3)cn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2coc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2cc(C3CC3)[nH]n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2ncc(C3CC3)cn2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2nccc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2nnc(C3CC3)o2)C1
InChIInChI=1S/C18H26N2O2.3C16H24N4O.C15H24N4O.C15H23N3O2.C14H22N4O2/c1-11(2)20-9-12(3)16(10-20)19-18(22)14-6-7-15(13-4-5-13)17(21)8-14;1-10(2)20-8-11(3)15(9-20)19-16(21)14-7-17-13(6-18-14)12-4-5-12;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-6-13(7-18-15)12-4-5-12;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-7-6-13(18-15)12-4-5-12;1-9(2)19-7-10(3)14(8-19)16-15(20)13-6-12(17-18-13)11-4-5-11;1-9(2)18-6-10(3)12(7-18)16-14(19)13-8-20-15(17-13)11-4-5-11;1-8(2)18-6-9(3)11(7-18)15-12(19)14-17-16-13(20-14)10-4-5-10/h6-7,11-13,16H,4-5,8-10H2,1-3H3,(H,19,22);6-7,10-12,15H,4-5,8-9H2,1-3H3,(H,19,21);2*6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-11,14H,4-5,7-8H2,1-3H3,(H,16,20)(H,17,18);8-12H,4-7H2,1-3H3,(H,16,19);8-11H,4-7H2,1-3H3,(H,15,19)/t12-,16-;11-,15-;2*11-,14+;10-,14+;10-,12-;9-,11+/m1100010/s1
InChIKeyBTRDQKPCXUKLKE-TXQLYQITSA-N
XLogP12.67
TPSA414.42 Ų
H-Bond Donors8
H-Bond Acceptors27
Rotatable Bonds28
Heavy Atoms145
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001999.71
LogP ≤ 512.67
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1027

Analyze 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;6-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyridazine-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;6-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-4-carboxamide
CID 157488419

Frequently Asked Questions

What is the IUPAC name of 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide?
The IUPAC name of 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide (CID 157458762) is 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide.
What is the SMILES notation for 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide?
The canonical SMILES for 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide is CC(C)N1C[C@@H](C)[C@H](NC(=O)C2=CC=C(C3CC3)C(=O)C2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2cnc(C3CC3)cn2)C1.CC(C)N1C[C@@H](C)[C@H](NC(=O)c2coc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2cc(C3CC3)[nH]n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2ncc(C3CC3)cn2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2nccc(C3CC3)n2)C1.CC(C)N1C[C@H](C)[C@H](NC(=O)c2nnc(C3CC3)o2)C1.
What is the InChIKey of 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide?
The InChIKey is BTRDQKPCXUKLKE-TXQLYQITSA-N. The full InChI is InChI=1S/C18H26N2O2.3C16H24N4O.C15H24N4O.C15H23N3O2.C14H22N4O2/c1-11(2)20-9-12(3)16(10-20)19-18(22)14-6-7-15(13-4-5-13)17(21)8-14;1-10(2)20-8-11(3)15(9-20)19-16(21)14-7-17-13(6-18-14)12-4-5-12;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-6-13(7-18-15)12-4-5-12;1-10(2)20-8-11(3)14(9-20)19-16(21)15-17-7-6-13(18-15)12-4-5-12;1-9(2)19-7-10(3)14(8-19)16-15(20)13-6-12(17-18-13)11-4-5-11;1-9(2)18-6-10(3)12(7-18)16-14(19)13-8-20-15(17-13)11-4-5-11;1-8(2)18-6-9(3)11(7-18)15-12(19)14-17-16-13(20-14)10-4-5-10/h6-7,11-13,16H,4-5,8-10H2,1-3H3,(H,19,22);6-7,10-12,15H,4-5,8-9H2,1-3H3,(H,19,21);2*6-7,10-12,14H,4-5,8-9H2,1-3H3,(H,19,21);6,9-11,14H,4-5,7-8H2,1-3H3,(H,16,20)(H,17,18);8-12H,4-7H2,1-3H3,(H,16,19);8-11H,4-7H2,1-3H3,(H,15,19)/t12-,16-;11-,15-;2*11-,14+;10-,14+;10-,12-;9-,11+/m1100010/s1.
What are the key properties of 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide?
5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide has a molecular weight of 1999.71 g/mol, XLogP of 12.67, 28 rotatable bonds, 8 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3,4-oxadiazole-2-carboxamide;2-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1,3-oxazole-4-carboxamide;4-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-5-oxocyclohexa-1,3-diene-1-carboxamide;5-cyclopropyl-N-[(3S,4R)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrazine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]-1H-pyrazole-3-carboxamide;4-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide;5-cyclopropyl-N-[(3S,4S)-4-methyl-1-propan-2-ylpyrrolidin-3-yl]pyrimidine-2-carboxamide is sourced from PubChem (CID 157458762), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).